This article is more than 5 years old. Information may no longer be current.

PDT may not stabilize visual acuity, lesion size in CNV, study shows

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Photodynamic therapy with verteporfin does not appear to effectively stabilize visual acuity and lesion size in choroidal neovascularization secondary to angioid streaks, a study found.

Luis Arias and colleagues retrospectively studied 10 eyes of 10 consecutive patients with choroidal neovascularization (CNV) secondary to angioid streaks. All patients were treated with standard PDT with verteporfin protocol.

The study found that mean visual acuity was 20/126 at baseline (range 20/40 to 20/320) and 20/500 at the final examination. Three patients lost less than three lines of visual acuity and four patients lost six lines. In total, patients lost a mean of 4.9 lines, the authors said.

Overall, however, results in the PDT-treated group appeared to be slightly better than in a control group of seven previously examined patients who had not undergone PDT, the study found.

The mean duration of follow up in the PDT group was 18 months, while in the control group mean follow up was 15 months.

The study was published in Graefe’s Archive for Clinical and Experimental Ophthalmology.